Citigroup’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Citigroup’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1	Closed	-$1K	–	7517
2016 Q1	$1K	Buy	+1	New	+$1.04K	﹤0.01%	7354
2015 Q4	–	Hold	0	–	–	–	7434
2015 Q2	–	Hold	0	–	-$1K	–	7813
2015 Q1	–	Hold	0	–	–	–	7092
2014 Q3	–	Sell	-2	Closed	-$9K	–	7352
2014 Q2	$9K	Buy	+2	New	+$10.1K	﹤0.01%	6229
2014 Q1	–	Sell	-1	Closed	-$8K	–	7243
2013 Q4	$8K	Buy	+1	New	+$5.62K	﹤0.01%	6492

Other funds holding NURO

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Citigroup's NURO Position: Q2 2016 in Review

Citigroup sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2016, closing a stake of 1 share — an estimated $1K sold.

Citigroup first reported a position in NURO in Q4 2013 and held it in 3 quarters. The position peaked at $9K in Q2 2014. 11 funds tracked by Wall St. Rank hold NURO as of Q2 2016.

Citigroup reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Citigroup sold 1 NeuroMetrix, Inc. Common Stock share in Q2 2016, an estimated $1K.
Citigroup first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
Citigroup's NeuroMetrix, Inc. Common Stock position peaked at $9K in Q2 2014.
11 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.